Sintx Technologies (NASDAQ:SINT – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued on Wednesday,Benzinga reports. They presently have a $10.00 price objective on the stock. HC Wainwright’s price objective indicates a potential upside of 354.55% from the stock’s previous close.
A number of other equities research analysts have also issued reports on SINT. Weiss Ratings reiterated a “sell (e+)” rating on shares of Sintx Technologies in a report on Tuesday, April 21st. Ascendiant Capital Markets reduced their price objective on Sintx Technologies from $16.00 to $12.00 and set a “buy” rating on the stock in a research note on Wednesday, April 8th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $11.00.
View Our Latest Research Report on SINT
Sintx Technologies Stock Down 1.3%
Sintx Technologies (NASDAQ:SINT – Get Free Report) last released its earnings results on Friday, May 15th. The company reported ($0.70) EPS for the quarter, missing analysts’ consensus estimates of ($0.66) by ($0.04). The company had revenue of $0.38 million for the quarter, compared to analysts’ expectations of $0.30 million. Sintx Technologies had a negative return on equity of 366.49% and a negative net margin of 1,058.60%. On average, analysts expect that Sintx Technologies will post -2.16 earnings per share for the current year.
Institutional Investors Weigh In On Sintx Technologies
A hedge fund recently raised its stake in Sintx Technologies stock. Geode Capital Management LLC raised its holdings in shares of Sintx Technologies, Inc. (NASDAQ:SINT – Free Report) by 33.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 15,339 shares of the company’s stock after acquiring an additional 3,848 shares during the quarter. Geode Capital Management LLC owned approximately 0.56% of Sintx Technologies worth $49,000 as of its most recent filing with the SEC. 18.38% of the stock is currently owned by institutional investors and hedge funds.
About Sintx Technologies
Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.
The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.
Read More
- Five stocks we like better than Sintx Technologies
- Palo Alto Networks Up 70%: Can the Rally Last Into June?
- Block’s Pivot to Profits and AI Is Turning Heads
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
